Current Issue February 2012, Vol. 18, No. 2

Issue Highlights

Reviews

Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson's disease: A systematic review
February 2012(Vol. 18 | No. 2 | Pages 117-124)
Dawn Tan, Mary Danoudis, Jennifer McGinley, Meg E. Morris

Hemiballismus: Current concepts and review
February 2012(Vol. 18 | No. 2 | Pages 125-129)
Jason S. Hawley, William J. Weiner

Papers

Loss of ability to work and ability to live independently in Parkinson’s disease
February 2012(Vol. 18 | No. 2 | Pages 130-135)
Barbara Jasinska-Myga, Michael G. Heckman, Christian Wider, John D. Putzke, Zbigniew K. Wszolek, Ryan J. Uitti

Parkinson’s disease and risk of hip fracture: An 8-year follow-up study in Taiwan
02 February 2012
Yen-Yu Chen, Pei-Yu Cheng, Shey-Lin Wu, Chien-Hsu Lai
Abstract: Background: Patients with Parkinson’s disease (PD) are subject to posture instability and falling. However, PD was not included as one of the risk factors in commonly used fracture risk calc...
Diffusion tensor imaging: Tract based spatial statistics study in essential tremor
01 February 2012
Jitender Saini, Bhavani Shankara Bagepally, Maya Dattatraya Bhatt, Vijay Chandran, Rose Dawn Bharath, Chandrajit Prasad, Ravi Yadav, Pramod Kumar Pal
Abstract: Introduction: Essential tremor (ET) is a common movement disorder with motor and non-motor symptoms. We aimed to investigate the neurodegenerative changes in the brain white matter of patien...
Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson’s disease
30 January 2012
Cassandra Peoples, Sharon Spana, Keyoumars Ashkan, Alim-Louis Benabid, Jonathan Stone, Gary E. Baker, John Mitrofanis
Abstract: We have shown previously that photobiomodulation or near-infrared light (NIr) treatment protects dopaminergic cells of the substantia nigra pars compacta (SNc) in an acute MPTP (1-methyl-4-p...
Apomorphine injections: Predictors of initial common adverse events and long term tolerability
27 January 2012
William G. Ondo, Christine Hunter, Joseph M. Ferrara, Giovanni Mostile
Abstract: Background: Apomorphine injections effectively abort “off” episodes in Parkinson’s disease (PD). However, their use is limited by actual and perceived adverse events (AE). To our knowledge, ...
Magnetization transfer and adiabatic R1ρ MRI in the brainstem of Parkinson’s disease
20 January 2012
Paul J. Tuite, Silvia Mangia, Andrew E. Tyan, Michael K. Lee, Michael Garwood, Shalom Michaeli
Abstract: Background: In addition to classic midbrain pathology, Parkinson’s disease (PD) is accompanied by changes in pontine and medullary brainstem structures. These additional abnormalities may un...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

Subscribe

Journal Ranking

Ranking 53rd out of the 185
in the ISI Clinical Neurology category

2010 Journal Impact Factor: 3.245
© Thomson Reuters Journal Citation Reports 2011

Publishing Information

Parkinsonism and Related Disorders is published by Elsevier

The WFN Association of Parkinsonism and Related Disorders is affiliated to Parkinsonism and Related Disorders.

Access this journal onSciVerse ScienceDirect

Journal Access

Full-text articles are available from 1998 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers.

Activate Online Access

About Parkinsonism and Related Disorders

Parkinsonism & Related Disorders is an established journal publishing the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which parkinsonism, essential tremor or related movement disorders may be a feature. It is included in PubMed/MEDLINE. Parkinsonism & Related Disorders is published 10 times a year.

About WFN Association of Parkinsonism and Related Disorders

Over 50 years ago, the WFN Association of Parkinsonism and Related Disorders was established by the World Federation of Neurology to promote and monitor research developments, as well as foster communication among neuroscientists in this field. It consists of max 150 full elected members and over 2,000 associate members from various countries throughout the world and holds regularly stated meetings. The Association sponsors a World Congress on Parkinson's disease and related disorders every two years, which evaluates progress and identifies promising areas for research. The most recent congress - 18th in the series - was held in Miami, Florida USA, December 2009. The XIX WFN World Congress on Parkinson's Disease and Related Disorders organized by this Association, will take place in exciting Shanghai in December 2011. See: http://www.prdassociation.org/ At various intervals, workshops on current issues in Parkinson's disease designed to produce consensus reports are organized. The Committee is especially committed to developing educational programs for physicians, as well as the lay public.